Tevogen Bio Appoints Tapan V Shah as Head of Investor Relations and Corporate Development Mr. Shah, a Wall Street veteran with over 25 years of experience, brings broad leadership capabilities to Tevogen Bio.

Semper Paratus Acquisition Corporation’s Shareholders Approve Business Combination with Tevogen Bio New York, NY, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Semper Paratus Acquisition Corporation (“Semper Paratus”) (Nasdaq: LGST, LGSTW, LGSTU), a publicly-traded special purpose acquisition company,...